The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis (Q40941566)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 1999

Language	Label	Description	Also known as
English	The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis	scientific article published on June 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

0 references

author name string

Jiang H

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Bielekova B

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Okazaki H

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Clarence-Smith K

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Johnson KP

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Bergey G

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Martin R

7

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Dhib-Jalbut S

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Journal of Neuroimmunology

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

134-145

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

T-cell tumor necrosis factor-alpha receptor binding in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

IFN-γ priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human T-cell response to myelin basic protein peptide (83-99): extensive heterogeneity in antigen recognition, function, and phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesnarinone is a selective inhibitor of macrophage TNF(alpha) release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesnarinone inhibits production of HIV-1 in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic AMP-dependent and cyclic AMP-independent actions of a novel cardiotonic agent, OPC-8212

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesnarinone: a potential cytokine inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-gene expression in measles-infected adult human glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900037-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-5728(99)00037-5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40941566&oldid=1910940004"